Recursion (RXRX) Form 144 Discloses August Insider Sales, New 100K Sale

Rhea-AI Filing Summary

Form 144 notice for Recursion Pharmaceuticals, Inc. (RXRX) reporting a proposed sale of 100,000 Class A shares through Fidelity Brokerage Services on 09/10/2025 with an aggregate market value of $471,000. The filing shows these shares were acquired as Founders Shares on 09/01/2016 and listed as compensation with 100,000 units subject to sale.

The filing also discloses securities sold in the past three months by related parties: Christopher C. Gibson sold 500,000 shares on 08/11/2025 for $2,640,000 and 100,000 shares on 08/26/2025 for $484,000; Gibson Family Trust sold 17,875 shares on 08/11/2025 for $94,380; Lahwran-3 LLC sold 100,000 shares on 08/11/2025 for $528,000. The filing lists 427,312,960 Class A shares outstanding.

Positive

• Full disclosure of recent related-party transactions with dates and gross proceeds
• Proposed sale includes broker and exact sale date, meeting Rule 144 reporting requirements
• Acquisition details provided (date and nature: Founders Shares acquired 09/01/2016)

Negative

• Multiple sizable insider-related sales in August 2025 totaling 717,875 shares with gross proceeds of $3,746,380
• Filing contains no remarks or explanation for the sales or any trading plans (no Rule 10b5-1 adoption date indicated)

Insights

Securities Analyst

TL;DR: Multiple related-party sales and a new proposed sale are disclosed; filing shows recent substantial dispositions by insiders.

The filing documents a proposed sale of 100,000 Class A shares valued at $471,000 and discloses prior insider-related sales totaling 717,875 shares over August 2025 with gross proceeds of $3,746,380. This is a straightforward Rule 144 notice providing required details on acquisition dates, nature of acquisition (founders shares), and method of sale (broker). The notice is compliance-focused and supplies concrete transaction dates and amounts.

Corporate Governance Expert

TL;DR: The filing shows transparent reporting of insider and related-party sales but does not include any explanatory remarks.

The document identifies the seller relationships and discloses that the shares to be sold were originally acquired as founders shares on 09/01/2016. It contains the broker name and sale date for the proposed transaction and provides a full list of recent sales with gross proceeds. The filing contains no additional commentary or statements about any trading plans, reliance on Rule 10b5-1, or material non-public information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	100000	471000.00	427312960	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/01/2016	Founders Shares	Issuer			100000	09/01/2016	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	500000	2640000.00
Gibson Family Trust 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	17875	94380.00
Lahwran-3 Llc 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/11/2025	100000	528000.00
Christopher C. Gibson 41 S Rio Grande Street Salt Lake City UT 84101	Class A	08/26/2025	100000	484000.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Recursion Pharmaceuticals (RXRX) disclose?

The notice discloses a proposed sale of 100,000 Class A shares on 09/10/2025 via Fidelity with an aggregate market value of $471,000 and lists related-party sales in August 2025.

Who sold shares according to the filing for RXRX?

The filing identifies Christopher C. Gibson, Gibson Family Trust, and Lahwran-3 LLC as sellers in recent transactions.

How many Class A shares were outstanding per the filing?

The filing reports 427,312,960 Class A shares outstanding.

When were the shares to be sold originally acquired?

The 100,000 shares proposed for sale were acquired as Founders Shares on 09/01/2016 and listed as compensation.

What were the gross proceeds of recent insider sales shown?

Recent sales in August 2025 generated gross proceeds totaling $3,746,380 across the disclosed sellers.